{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T02:34:37Z","timestamp":1782182077096,"version":"3.54.5"},"reference-count":166,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatologic Clinics"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.det.2010.03.008","type":"journal-article","created":{"date-parts":[[2010,5,28]],"date-time":"2010-05-28T06:01:09Z","timestamp":1275026469000},"page":"535-545","source":"Crossref","is-referenced-by-count":32,"title":["Innovative Use of Topical Calcineurin Inhibitors"],"prefix":"10.1016","volume":"28","author":[{"given":"Andrew N.","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.det.2010.03.008_bib1","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1600-051X.2007.01191.x","article-title":"Comparative effect of tacrolimus 0.1% ointment and clobetasol 0.05% ointment in patients with oral lichen planus","volume":"35","author":"Corrocher","year":"2008","journal-title":"J Clin Periodontol"},{"issue":"2","key":"10.1016\/j.det.2010.03.008_bib2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.tripleo.2007.07.029","article-title":"A comparative treatment study of topical tacrolimus and clobetasol in oral lichen planus","volume":"105","author":"Radfar","year":"2008","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"5","key":"10.1016\/j.det.2010.03.008_bib3","first-page":"466","article-title":"Long-term efficacy and safety of topical tacrolimus in the management of ulcerative\/erosive oral lichen planus","volume":"13","author":"Hodgson","year":"2003","journal-title":"Eur J Dermatol"},{"issue":"2","key":"10.1016\/j.det.2010.03.008_bib4","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1046\/j.1365-2133.1999.02672.x","article-title":"Erosive mucosal lichen planus: response to topical treatment with tacrolimus","volume":"140","author":"Vente","year":"1999","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.det.2010.03.008_bib5","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1067\/mjd.2002.126275","article-title":"An open trial of topical tacrolimus for erosive oral lichen planus","volume":"47","author":"Morrison","year":"2002","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.det.2010.03.008_bib6","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/archderm.138.10.1335","article-title":"Treatment of chronic erosive oral lichen planus with low concentrations of topical tacrolimus: an open prospective study","volume":"138","author":"Olivier","year":"2002","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1016\/j.det.2010.03.008_bib7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1067\/mjd.2002.120535","article-title":"Management of recalcitrant ulcerative oral lichen planus with topical tacrolimus","volume":"46","author":"Kaliakatsou","year":"2002","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.det.2010.03.008_bib8","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2340\/00015555-0070","article-title":"A comparison of treatment of oral lichen planus with topical tacrolimus and triamcinolone acetonide ointment","volume":"86","author":"Laeijendecker","year":"2006","journal-title":"Acta Derm Venereol"},{"issue":"5","key":"10.1016\/j.det.2010.03.008_bib9","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1080\/09546630410018247","article-title":"Treatment of erosive oral lichen planus with topical tacrolimus","volume":"15","author":"Thomson","year":"2004","journal-title":"J Dermatolog Treat"},{"issue":"1","key":"10.1016\/j.det.2010.03.008_bib10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1067\/mjd.2002.119648","article-title":"Topical tacrolimus in the treatment of symptomatic oral lichen planus: a series of 13 patients","volume":"46","author":"Rozycki","year":"2002","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"10.1016\/j.det.2010.03.008_bib11","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1001\/archderm.140.12.1508","article-title":"Response of oral lichen planus to topical tacrolimus in 37 patients","volume":"140","author":"Byrd","year":"2004","journal-title":"Arch Dermatol"},{"issue":"4","key":"10.1016\/j.det.2010.03.008_bib12","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/j.1365-2133.2008.08726.x","article-title":"Pimecrolimus cream 1% in erosive oral lichen planus\u2013a prospective randomized double-blind vehicle-controlled study","volume":"159","author":"Volz","year":"2008","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.det.2010.03.008_bib13","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1001\/archderm.143.4.472","article-title":"Treatment of oral erosive lichen planus with 1% pimecrolimus cream: a double-blind, randomized, prospective trial with measurement of pimecrolimus levels in the blood","volume":"143","author":"Passeron","year":"2007","journal-title":"Arch Dermatol"},{"issue":"5","key":"10.1016\/j.det.2010.03.008_bib14","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.jaad.2007.06.022","article-title":"Randomized trial of pimecrolimus cream versus triamcinolone acetonide paste in the treatment of oral lichen planus","volume":"57","author":"Gorouhi","year":"2007","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"10.1016\/j.det.2010.03.008_bib15","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1001\/archderm.140.9.1065","article-title":"Topical tacrolimus and the 308-nm excimer laser: a synergistic combination for the treatment of vitiligo","volume":"140","author":"Passeron","year":"2004","journal-title":"Arch Dermatol"},{"issue":"2 Pt 1","key":"10.1016\/j.det.2010.03.008_bib16","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1524-4725.2004.30058.x","article-title":"Combined excimer laser and topical tacrolimus for the treatment of vitiligo: a pilot study","volume":"30","author":"Kawalek","year":"2004","journal-title":"Dermatol Surg"},{"issue":"7","key":"10.1016\/j.det.2010.03.008_bib17","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1001\/archderm.142.7.927","article-title":"A randomized, placebo-controlled, double-blind trial comparing narrowband UV-B Plus 0.1% tacrolimus ointment with narrowband UV-B plus placebo in the treatment of generalized vitiligo","volume":"142","author":"Mehrabi","year":"2006","journal-title":"Arch Dermatol"},{"issue":"5","key":"10.1016\/j.det.2010.03.008_bib18","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1001\/archderm.139.5.581","article-title":"A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo","volume":"139","author":"Lepe","year":"2003","journal-title":"Arch Dermatol"},{"issue":"8","key":"10.1016\/j.det.2010.03.008_bib19","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/j.1468-3083.2009.03138.x","article-title":"Response of vitiligo to once- vs. twice-daily topical tacrolimus: a controlled prospective, randomized, observer-blinded trial","volume":"23","author":"Radakovic","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"7","key":"10.1016\/j.det.2010.03.008_bib20","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/j.1468-3083.2006.02101.x","article-title":"Narrow-band UVB phototherapy combined with tacrolimus ointment in vitiligo: a review of 110 patients","volume":"21","author":"Fai","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.det.2010.03.008_bib21","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1001\/archderm.142.2.252","article-title":"Lack of efficacy of tacrolimus in the treatment of vitiligo in the absence of UV-B exposure","volume":"142","author":"Ostovari","year":"2006","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1016\/j.det.2010.03.008_bib22","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1365-4632.2009.03852.x","article-title":"Efficacy and safety of tacrolimus cream 0.1% in the treatment of vitiligo","volume":"48","author":"Xu","year":"2009","journal-title":"Int J Dermatol"},{"issue":"1","key":"10.1016\/j.det.2010.03.008_bib23","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jaad.2003.12.031","article-title":"Topical tacrolimus therapy for vitiligo: therapeutic responses and skin messenger RNA expression of proinflammatory cytokines","volume":"51","author":"Grimes","year":"2004","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.det.2010.03.008_bib24","doi-asserted-by":"crossref","first-page":"474","DOI":"10.2340\/00015555-0464","article-title":"Occlusive treatment enhances efficacy of tacrolimus 0.1% ointment in adult patients with vitiligo: results of a placebo-controlled 12-month prospective study","volume":"88","author":"Hartmann","year":"2008","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"10.1016\/j.det.2010.03.008_bib25","first-page":"158","article-title":"Tacrolimus ointment 0.1% produces repigmentation in patients with vitiligo: results of a prospective patient series","volume":"71","author":"Tanghetti","year":"2003","journal-title":"Cutis"},{"issue":"6","key":"10.1016\/j.det.2010.03.008_bib26","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1365-2230.2004.01632.x","article-title":"Topical tacrolimus for treatment of childhood vitiligo in Asians","volume":"29","author":"Kanwar","year":"2004","journal-title":"Clin Exp Dermatol"},{"issue":"5","key":"10.1016\/j.det.2010.03.008_bib27","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.jaad.2004.05.036","article-title":"Tacrolimus ointment promotes repigmentation of vitiligo in children: a review of 57 cases","volume":"51","author":"Silverberg","year":"2004","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"10.1016\/j.det.2010.03.008_bib28","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1346-8138.2008.00511.x","article-title":"Topical immunomodulators are effective for treatment of vitiligo","volume":"35","author":"Choi","year":"2008","journal-title":"J\u00a0Dermatol"},{"issue":"1","key":"10.1016\/j.det.2010.03.008_bib29","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/09546630802155057","article-title":"The efficacy of pimecrolimus 1% cream plus narrow-band ultraviolet B in the treatment of vitiligo: a double-blind, placebo-controlled clinical trial","volume":"20","author":"Esfandiarpour","year":"2009","journal-title":"J\u00a0Dermatolog Treat"},{"issue":"3 Suppl 1","key":"10.1016\/j.det.2010.03.008_bib30","first-page":"P168","article-title":"Efficacy and safety of pimecrolimus (ASM 981) 1% in the treatment of vitiligo","volume":"52","author":"Atwa","year":"2005","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"10.1016\/j.det.2010.03.008_bib31","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/j.1610-0387.2006.06124.x","article-title":"Efficacy and safety of pimecrolimus cream 1% in adult patients with vitiligo: results of a randomized, double-blind, vehicle-controlled study","volume":"4","author":"Dawid","year":"2006","journal-title":"J Dtsch Dermatol Ges"},{"issue":"2 (Suppl 2)","key":"10.1016\/j.det.2010.03.008_bib32","first-page":"AB170","article-title":"A double-blind randomized trial of 1% pimecrolimus versus 0.05% clobetasol propionate for the treatment of vitiligo","volume":"56","author":"Seckin","year":"2007","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.det.2010.03.008_bib33","first-page":"55","article-title":"Topical pimecrolimus in the treatment of vitiligo","volume":"17","author":"Boone","year":"2007","journal-title":"Eur J Dermatol"},{"issue":"6","key":"10.1016\/j.det.2010.03.008_bib34","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1080\/09546630601028711","article-title":"Topical pimecrolimus: a new horizon for vitiligo treatment?","volume":"17","author":"Sendur","year":"2006","journal-title":"J Dermatolog Treat"},{"issue":"3","key":"10.1016\/j.det.2010.03.008_bib35","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1159\/000099592","article-title":"Pimecrolimus cream in repigmentation of vitiligo","volume":"214","author":"Seirafi","year":"2007","journal-title":"Dermatology"},{"issue":"2","key":"10.1016\/j.det.2010.03.008_bib36","first-page":"88","article-title":"Topical 0.05% clobetasol propionate versus 1% pimecrolimus ointment in vitiligo","volume":"15","author":"Coskun","year":"2005","journal-title":"Eur J Dermatol"},{"issue":"5","key":"10.1016\/j.det.2010.03.008_bib37","first-page":"517","article-title":"Retrospective analysis of pimecrolimus cream 1% for treatment of facial vitiligo","volume":"6","author":"Mayoral","year":"2007","journal-title":"J Drugs Dermatol"},{"issue":"1","key":"10.1016\/j.det.2010.03.008_bib38","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1468-3083.2008.02668.x","article-title":"Two therapeutic challenges: facial vitiligo successfully treated with 1% pimecrolimus cream and 0.005% calcipotriol cream","volume":"23","author":"Bilac","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.det.2010.03.008_bib39","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1159\/000073099","article-title":"Repigmentation of vitiligo with pimecrolimus cream: a case report","volume":"207","author":"Mayoral","year":"2003","journal-title":"Dermatology"},{"key":"10.1016\/j.det.2010.03.008_bib40","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/j.1365-4632.2007.03282.x","article-title":"Two therapeutic challenges: periocular and genital vitiligo in children successfully treated with pimecrolimus cream","volume":"46","author":"Souza Leite","year":"2007","journal-title":"Int J Dermatol"},{"issue":"6","key":"10.1016\/j.det.2010.03.008_bib41","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1684\/ejd.2009.0779","article-title":"An open randomized study to compare narrow band UVB, topical pimecrolimus and topical tacrolimus in the treatment of vitiligo","volume":"19","author":"Stinco","year":"2009","journal-title":"Eur J Dermatol"},{"issue":"3","key":"10.1016\/j.det.2010.03.008_bib42","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1525-1470.2009.00926.x","article-title":"The efficacy of pimecrolimus 1% cream combined with microdermabrasion in the treatment of nonsegmental childhood vitiligo: a randomized placebo-controlled study","volume":"26","author":"Farajzadeh","year":"2009","journal-title":"Pediatr Dermatol"},{"issue":"3","key":"10.1016\/j.det.2010.03.008_bib43","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1525-1470.2009.00914.x","article-title":"Combination of 308-nm excimer laser with topical pimecrolimus for the treatment of childhood vitiligo","volume":"26","author":"Hui-Lan","year":"2009","journal-title":"Pediatr Dermatol"},{"issue":"5","key":"10.1016\/j.det.2010.03.008_bib44","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jaad.2004.07.011","article-title":"Tacrolimus ointment is effective for facial and intertriginous psoriasis","volume":"51","author":"Lebwohl","year":"2004","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.det.2010.03.008_bib45","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/archderm.141.1.43","article-title":"Topical tacrolimus ointment combined with 6% salicylic acid gel for plaque psoriasis treatment","volume":"141","author":"Carroll","year":"2005","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1016\/j.det.2010.03.008_bib46","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1046\/j.1365-2133.1999.02927.x","article-title":"Tacrolimus ointment improves psoriasis in a microplaque assay","volume":"141","author":"Remitz","year":"1999","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.det.2010.03.008_bib47","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/j.1365-2133.2007.08201.x","article-title":"Comparison of cutaneous tolerance and efficacy of calcitriol 3 microg g(-1) ointment and tacrolimus 0.3 mg g(-1) ointment in chronic plaque psoriasis involving facial or genitofemoral areas: a double-blind, randomized controlled trial","volume":"157","author":"Liao","year":"2007","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.det.2010.03.008_bib48","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1046\/j.1365-2133.2003.05426.x","article-title":"Topical tacrolimus for facial psoriasis","volume":"149","author":"Clayton","year":"2003","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.det.2010.03.008_bib49","first-page":"471","article-title":"Topical tacrolimus: an effective therapy for facial psoriasis","volume":"13","author":"Yamamoto","year":"2003","journal-title":"Eur J Dermatol"},{"issue":"4","key":"10.1016\/j.det.2010.03.008_bib50","first-page":"141","article-title":"Successful treatment of genital and facial psoriasis with tacrolimus ointment 0.1%","volume":"31","author":"Rallis","year":"2005","journal-title":"Drugs Exp Clin Res"},{"issue":"4","key":"10.1016\/j.det.2010.03.008_bib51","first-page":"334","article-title":"Topical tacrolimus for the treatment of psoriasis on the face, genitalia, intertriginous areas and corporal plaques","volume":"5","author":"Martin","year":"2006","journal-title":"J Drugs Dermatol"},{"issue":"1","key":"10.1016\/j.det.2010.03.008_bib52","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1525-1470.2007.00341.x","article-title":"Tacrolimus ointment is effective for psoriasis on the face and intertriginous areas in pediatric patients","volume":"24","author":"Brune","year":"2007","journal-title":"Pediatr Dermatol"},{"issue":"4","key":"10.1016\/j.det.2010.03.008_bib53","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1067\/mjd.2003.169","article-title":"Tacrolimus ointment for the treatment of psoriasis on the face and intertriginous areas","volume":"48","author":"Freeman","year":"2003","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.det.2010.03.008_bib54","doi-asserted-by":"crossref","first-page":"230","DOI":"10.2310\/7750.2008.07055","article-title":"Efficacy and tolerability of topical tacrolimus ointment for the treatment of male genital psoriasis","volume":"12","author":"Bissonnette","year":"2008","journal-title":"J Cutan Med Surg"},{"issue":"5","key":"10.1016\/j.det.2010.03.008_bib55","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.jaad.2004.06.010","article-title":"Pimecrolimus cream 1% in the treatment of intertriginous psoriasis: a double-blind, randomized study","volume":"51","author":"Gribetz","year":"2004","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.det.2010.03.008_bib56","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1080\/00015550310003791","article-title":"An experimental ointment formulation of pimecrolimus is effective in psoriasis without occlusion","volume":"83","author":"Mrowietz","year":"2003","journal-title":"Acta Derm Venereol"},{"issue":"9","key":"10.1016\/j.det.2010.03.008_bib57","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1001\/archderm.142.9.1138","article-title":"1% pimecrolimus, 0.005% calcipotriol, and 0.1% betamethasone in the treatment of intertriginous psoriasis: a double-blind, randomized controlled study","volume":"142","author":"Kreuter","year":"2006","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.det.2010.03.008_bib58","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000111510","article-title":"Pimecrolimus 1% cream in the treatment of facial psoriasis: a 16-week open-label study","volume":"216","author":"Jacobi","year":"2008","journal-title":"Dermatology"},{"issue":"1","key":"10.1016\/j.det.2010.03.008_bib59","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jaad.2006.03.025","article-title":"A prospective randomized clinical trial of 0.1% tacrolimus ointment in a model of chronic allergic contact dermatitis","volume":"55","author":"Belsito","year":"2006","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.det.2010.03.008_bib60","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1067\/S0190-9622(03)01826-7","article-title":"Tacrolimus ointment 0.1% in the treatment of nickel-induced allergic contact dermatitis","volume":"49","author":"Saripalli","year":"2003","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.det.2010.03.008_bib61","doi-asserted-by":"crossref","first-page":"527","DOI":"10.2500\/aap.2006.27.2915","article-title":"Tacrolimus ointment in nickel sulphate-induced steroid-resistant allergic contact dermatitis","volume":"27","author":"Pacor","year":"2006","journal-title":"Allergy Asthma Proc"},{"issue":"6","key":"10.1016\/j.det.2010.03.008_bib62","first-page":"349","article-title":"SDZ ASM 981 is the first non-steroid that suppresses established nickel contact dermatitis elicited by allergen challenge","volume":"42","author":"Queille-Roussel","year":"2000","journal-title":"Contact Dermatitis"},{"issue":"1","key":"10.1016\/j.det.2010.03.008_bib63","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2310\/6620.2007.06031","article-title":"A double-blind randomized placebo-controlled pilot study comparing topical immunomodulating agents and corticosteroids for treatment of experimentally induced nickel contact dermatitis","volume":"18","author":"Bhardwaj","year":"2007","journal-title":"Dermatitis"},{"issue":"4","key":"10.1016\/j.det.2010.03.008_bib64","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1468-3083.2008.03056.x","article-title":"Tacrolimus ointment 0.1% in the treatment of allergic contact eyelid dermatitis","volume":"23","author":"Katsarou","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.det.2010.03.008_bib65","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.0105-1873.2005.00664.x","article-title":"Eyeglass frame allergic contact dermatitis: does tacrolimus prevent recurrences?","volume":"53","author":"Nakada","year":"2005","journal-title":"Contact Dermatitis"},{"issue":"3","key":"10.1016\/j.det.2010.03.008_bib66","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1159\/000093249","article-title":"Modulation of atopy patch test and skin prick test by pretreatment with 1% pimecrolimus cream","volume":"140","author":"Weissenbacher","year":"2006","journal-title":"Int Arch Allergy Immunol"},{"issue":"9","key":"10.1016\/j.det.2010.03.008_bib67","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1111\/j.1365-4632.2008.03634.x","article-title":"Treatment with pimecrolimus cream 1% clears irritant dermatitis of the periocular region, face and neck","volume":"47","author":"Mensing","year":"2008","journal-title":"Int J\u00a0Dermatol"},{"issue":"2","key":"10.1016\/j.det.2010.03.008_bib68","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/15569520801946938","article-title":"Acute actinic cheilitis-like chemical irritant reaction following accidental contact with ethylene glycol-favorable response to topical 1% pimecrolimus cream: a case report","volume":"27","author":"Erkek","year":"2008","journal-title":"Cutan Ocul Toxicol"},{"issue":"3","key":"10.1016\/j.det.2010.03.008_bib69","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/09546630802562443","article-title":"Successful management of a delayed and persistent cutaneous reaction to jellyfish with pimecrolimus","volume":"20","author":"Di Costanzo","year":"2009","journal-title":"J\u00a0Dermatolog Treat"},{"issue":"1","key":"10.1016\/j.det.2010.03.008_bib70","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1067\/mjd.2003.450","article-title":"An open pilot study using tacrolimus ointment in the treatment of seborrheic dermatitis","volume":"49","author":"Meshkinpour","year":"2003","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.det.2010.03.008_bib71","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1046\/j.1365-2133.2003.05383.x","article-title":"Tacrolimus 0.1% ointment for seborrhoeic dermatitis: an open-label pilot study","volume":"148","author":"Braza","year":"2003","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.det.2010.03.008_bib72","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jaad.2006.11.007","article-title":"Results of a randomized, double-blind, vehicle-controlled efficacy trial of pimecrolimus cream 1% for the treatment of moderate to severe facial seborrheic dermatitis","volume":"57","author":"Warshaw","year":"2007","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"10.1016\/j.det.2010.03.008_bib73","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1001\/archderm.142.8.1066","article-title":"Pimecrolimus cream, 1%, vs hydrocortisone acetate cream, 1%, in the treatment of facial seborrheic dermatitis: a randomized, investigator-blind, clinical trial","volume":"142","author":"Firooz","year":"2006","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1016\/j.det.2010.03.008_bib74","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1080\/09546630802286993","article-title":"An open, randomized, prospective, comparative study of topical pimecrolimus 1% cream and topical ketoconazole 2% cream in the treatment of seborrheic dermatitis","volume":"20","author":"Koc","year":"2009","journal-title":"J\u00a0Dermatolog Treat"},{"issue":"6","key":"10.1016\/j.det.2010.03.008_bib75","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3109\/09546630802687349","article-title":"Pimecrolimus 1% cream, methylprednisolone aceponate 0.1% cream and metronidazole 0.75% gel in the treatment of seborrhoeic dermatitis: a randomized clinical study","volume":"20","author":"Cicek","year":"2009","journal-title":"J Dermatolog Treat"},{"issue":"1","key":"10.1016\/j.det.2010.03.008_bib76","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0190-9622(03)02157-1","article-title":"Tacrolimus effect on rosacea","volume":"50","author":"Bamford","year":"2004","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.det.2010.03.008_bib77","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1468-3083.2008.02822.x","article-title":"Clinical efficacy of tacrolimus in rosacea","volume":"23","author":"Garg","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.det.2010.03.008_bib78","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/j.1365-2133.2006.07669.x","article-title":"Pimecrolimus cream 1% for papulopustular rosacea: a randomized vehicle-controlled double-blind trial","volume":"156","author":"Weissenbacher","year":"2007","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.det.2010.03.008_bib79","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.1468-3083.2008.02589.x","article-title":"A randomized, single-blind, placebo-controlled, split-face study with pimecrolimus cream 1% for papulopustular rosacea","volume":"22","author":"Karabulut","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.det.2010.03.008_bib80","article-title":"A comparison of metronidazole 1% cream and pimecrolimus 1% cream in the treatment of patients with papulopustular rosacea: a randomized open-label clinical trial","author":"Koca","year":"2009","journal-title":"Clin Exp Dermatol"},{"issue":"5","key":"10.1016\/j.det.2010.03.008_bib81","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1365-2133.2008.08496.x","article-title":"Pimecrolimus 1% cream for the treatment of steroid-induced rosacea: an 8-week split-face clinical trial","volume":"158","author":"Lee","year":"2008","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.det.2010.03.008_bib82","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1468-3083.2006.01991.x","article-title":"An open-label pilot study to evaluate the safety and efficacy of topically applied pimecrolimus cream for the treatment of steroid-induced rosacea-like eruption","volume":"21","author":"Chu","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.det.2010.03.008_bib83","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1365-2133.2006.07595.x","article-title":"Tacrolimus vs. clobetasol propionate in the treatment of facial cutaneous lupus erythematosus: a randomized, double-blind, bilateral comparison study","volume":"156","author":"Tzung","year":"2007","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.det.2010.03.008_bib84","first-page":"50","article-title":"Topical FK506 (tacrolimus) therapy for facial erythematous lesions of cutaneous lupus erythematosus and dermatomyositis","volume":"12","author":"Yoshimasu","year":"2002","journal-title":"Eur J Dermatol"},{"issue":"2","key":"10.1016\/j.det.2010.03.008_bib85","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1046\/j.1365-2133.2002.488616.x","article-title":"The effect of topical tacrolimus on severe recalcitrant chronic discoid lupus erythematosus","volume":"147","author":"Walker","year":"2002","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.det.2010.03.008_bib86","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1159\/000074119","article-title":"Topical tacrolimus as a therapeutic adjunct in patients with cutaneous lupus erythematosus. A report of three cases","volume":"207","author":"Bohm","year":"2003","journal-title":"Dermatology"},{"issue":"2","key":"10.1016\/j.det.2010.03.008_bib87","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1365-2133.2003.05186.x","article-title":"Efficacy of topical tacrolimus for treating the malar rash of systemic lupus erythematosus","volume":"148","author":"Kanekura","year":"2003","journal-title":"Br J Dermatol"},{"issue":"11","key":"10.1016\/j.det.2010.03.008_bib88","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1093\/rheumatology\/keh325","article-title":"Topical tacrolimus therapy of resistant cutaneous lesions in lupus erythematosus: a possible alternative","volume":"43","author":"Lampropoulos","year":"2004","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.det.2010.03.008_bib89","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/09546630310017852","article-title":"0.1% Tacrolimus ointment in a patient with subacute cutaneous lupus erythematosus","volume":"15","author":"Druke","year":"2004","journal-title":"J Dermatolog Treat"},{"issue":"12","key":"10.1016\/j.det.2010.03.008_bib90","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/j.1346-8138.2006.00203.x","article-title":"Successful treatment with topical tacrolimus in four cases of discoid lupus erythematosus","volume":"33","author":"Sugano","year":"2006","journal-title":"J Dermatol"},{"issue":"9","key":"10.1016\/j.det.2010.03.008_bib91","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1001\/archderm.141.9.1170","article-title":"0.1% tacrolimus ointment in the treatment of discoid lupus erythematosus","volume":"141","author":"Heffernan","year":"2005","journal-title":"Arch Dermatol"},{"issue":"7","key":"10.1016\/j.det.2010.03.008_bib92","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/j.1365-2230.2008.03138.x","article-title":"Pimecrolimus 1% cream versus betamethasone 17-valerate 0.1% cream in the treatment of facial discoid lupus erythematosus: a double-blind, randomized pilot study","volume":"34","author":"Barikbin","year":"2009","journal-title":"Clin Exp Dermatol"},{"issue":"12","key":"10.1016\/j.det.2010.03.008_bib93","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1093\/rheumatology\/kei093","article-title":"Pimecrolimus 1% cream for the treatment of discoid lupus erythematosus","volume":"44","author":"Tlacuilo-Parra","year":"2005","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.det.2010.03.008_bib94","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jaad.2004.01.044","article-title":"Pimecrolimus 1% cream for cutaneous lupus erythematosus","volume":"51","author":"Kreuter","year":"2004","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.det.2010.03.008_bib95","doi-asserted-by":"crossref","first-page":"25","DOI":"10.5070\/D31XH7Z688","article-title":"Treatment of cutaneous lupus with Elidel","volume":"8","author":"Zabawski","year":"2002","journal-title":"Dermatol Online J"},{"issue":"1","key":"10.1016\/j.det.2010.03.008_bib96","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jaad.2008.03.043","article-title":"A randomized, double-blind, vehicle-controlled study of 1% pimecrolimus cream in adult patients with perioral dermatitis","volume":"59","author":"Schwarz","year":"2008","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"10.1016\/j.det.2010.03.008_bib97","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1111\/j.1468-3083.2007.02191.x","article-title":"Pimecrolimus cream (1%) efficacy in perioral dermatitis - results of a randomized, double-blind, vehicle-controlled study in 40 patients","volume":"21","author":"Oppel","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.det.2010.03.008_bib98","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/ibd.20073","article-title":"Topical tacrolimus in the treatment of perianal Crohn's disease: exploratory randomized controlled trial","volume":"13","author":"Hart","year":"2007","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"10.1016\/j.det.2010.03.008_bib99","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1136\/gut.47.3.436","article-title":"Topical tacrolimus may be effective in the treatment of oral and perineal Crohn's disease","volume":"47","author":"Casson","year":"2000","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.det.2010.03.008_bib100","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/00005176-200102000-00022","article-title":"Systemic absorption with complications during topical tacrolimus treatment for orofacial Crohn disease","volume":"32","author":"Russell","year":"2001","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"5","key":"10.1016\/j.det.2010.03.008_bib101","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/j.1365-2133.2006.07446.x","article-title":"Multicentre, phase II trial on the safety and efficacy of topical tacrolimus ointment for the treatment of lichen sclerosus","volume":"155","author":"Hengge","year":"2006","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.det.2010.03.008_bib102","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2340\/00015555-0171","article-title":"Vulvar lichen sclerosus: 11 women treated with tacrolimus 0.1% ointment","volume":"87","author":"Virgili","year":"2007","journal-title":"Acta Derm Venereol"},{"issue":"7","key":"10.1016\/j.det.2010.03.008_bib103","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/j.1471-0528.2006.00977.x","article-title":"Topical tacrolimus in the management of lichen sclerosus","volume":"113","author":"Luesley","year":"2006","journal-title":"BJOG"},{"issue":"4","key":"10.1016\/j.det.2010.03.008_bib104","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.eururo.2008.03.013","article-title":"Safety and tolerability of adjuvant topical tacrolimus treatment in boys with lichen sclerosus: a prospective phase 2 study","volume":"54","author":"Ebert","year":"2008","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.det.2010.03.008_bib105","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1067\/mjd.2003.8","article-title":"Tacrolimus ointment for the treatment of vulvar lichen sclerosus","volume":"48","author":"Assmann","year":"2003","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.det.2010.03.008_bib106","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1346-8138.2006.00228.x","article-title":"Successful treatment of vulvar lichen sclerosus in a child with low-concentration topical tacrolimus ointment","volume":"34","author":"Matsumoto","year":"2007","journal-title":"J Dermatol"},{"issue":"7","key":"10.1016\/j.det.2010.03.008_bib107","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1001\/archderm.139.7.850","article-title":"Successful treatment of vulvar lichen sclerosus with topical tacrolimus","volume":"139","author":"Kunstfeld","year":"2003","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1016\/j.det.2010.03.008_bib108","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ejogrb.2005.03.012","article-title":"Vulvar lichen sclerosus successfully treated with topical tacrolimus","volume":"123","author":"Ginarte","year":"2005","journal-title":"Eur J\u00a0Obstet Gynecol Reprod Biol"},{"issue":"7","key":"10.1016\/j.det.2010.03.008_bib109","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1001\/archderm.139.7.922","article-title":"Successful treatment of anogenital lichen sclerosus with topical tacrolimus","volume":"139","author":"Bohm","year":"2003","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1016\/j.det.2010.03.008_bib110","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2165\/00128071-200809030-00006","article-title":"Significant improvement in extensive lichen sclerosus with tacrolimus ointment and PUVA","volume":"9","author":"Valdivielso-Ramos","year":"2008","journal-title":"Am J Clin Dermatol"},{"issue":"6","key":"10.1016\/j.det.2010.03.008_bib111","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1468-3083.2007.02469.x","article-title":"Lichen sclerosus et atrophicus of the lip: successful treatment with topical tacrolimus","volume":"22","author":"Wakamatsu","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"10","key":"10.1016\/j.det.2010.03.008_bib112","first-page":"778","article-title":"Pimecrolimus for the treatment of vulvar lichen sclerosus: a report of 4 cases","volume":"49","author":"Goldstein","year":"2004","journal-title":"J Reprod Med"},{"issue":"3","key":"10.1016\/j.det.2010.03.008_bib113","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000096736","article-title":"Pimecrolimus cream 1% in the treatment of lichen sclerosus","volume":"63","author":"Nissi","year":"2007","journal-title":"Gynecol Obstet Invest"},{"issue":"5","key":"10.1016\/j.det.2010.03.008_bib114","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1365-4632.2006.03185.x","article-title":"Pimecrolimus 1% cream in the treatment of vulvar lichen sclerosus in postmenopausal women","volume":"46","author":"Oskay","year":"2007","journal-title":"Int J Dermatol"},{"issue":"1","key":"10.1016\/j.det.2010.03.008_bib115","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jpag.2003.11.013","article-title":"Pimecrolimus for the treatment of vulvar lichen sclerosus in a premenarchal girl","volume":"17","author":"Goldstein","year":"2004","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"12","key":"10.1016\/j.det.2010.03.008_bib116","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1111\/j.1346-8138.2004.tb00646.x","article-title":"Unsuccessful treatment of extragenital lichen sclerosus with topical 1% pimecrolimus cream","volume":"31","author":"Arican","year":"2004","journal-title":"J Dermatol"},{"issue":"3","key":"10.1016\/j.det.2010.03.008_bib117","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2165\/00128071-200910030-00004","article-title":"Efficacy of topical tacrolimus 0.1% in active plaque morphea: randomized, double-blind, emollient-controlled pilot study","volume":"10","author":"Kroft","year":"2009","journal-title":"Am J Clin Dermatol"},{"issue":"11","key":"10.1016\/j.det.2010.03.008_bib118","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/j.1346-8138.2008.00552.x","article-title":"Topical tacrolimus 0.1% ointment in the treatment of localized scleroderma. An open label clinical and histological study","volume":"35","author":"Stefanaki","year":"2008","journal-title":"J Dermatol"},{"issue":"6","key":"10.1016\/j.det.2010.03.008_bib119","first-page":"747","article-title":"Significant absorption of topical tacrolimus in 3 patients with Netherton syndrome","volume":"137","author":"Allen","year":"2001","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1016\/j.det.2010.03.008_bib120","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jaad.2004.05.019","article-title":"Topical tacrolimus in alopecia areata","volume":"52","author":"Price","year":"2005","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.det.2010.03.008_bib121","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1046\/j.1365-2133.2002.500210.x","article-title":"Is topical tacrolimus effective in alopecia areata universalis?","volume":"147","author":"Feldmann","year":"2002","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.det.2010.03.008_bib122","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/000155502320624203","article-title":"Topical tacrolimus (FK506): treatment failure in four cases of alopecia universalis","volume":"82","author":"Park","year":"2002","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"10.1016\/j.det.2010.03.008_bib123","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1001\/archderm.136.1.124","article-title":"Topical tacrolimus: treatment failure in a patient with alopecia areata","volume":"136","author":"Thiers","year":"2000","journal-title":"Arch Dermatol"},{"issue":"3 Pt 1","key":"10.1016\/j.det.2010.03.008_bib124","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.jaad.2004.08.050","article-title":"Lack of efficacy of tacrolimus ointment 0.1% for treatment of hemodialysis-related pruritus: a randomized, double-blind, vehicle-controlled study","volume":"52","author":"Duque","year":"2005","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.det.2010.03.008_bib125","doi-asserted-by":"crossref","first-page":"6","DOI":"10.5070\/D30S33H12T","article-title":"Frontal fibrosing alopecia","volume":"11","author":"Clark-Loeser","year":"2005","journal-title":"Dermatol Online J"},{"issue":"3","key":"10.1016\/j.det.2010.03.008_bib126","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1365-2230.2004.01713.x","article-title":"Factitious panniculitis masquerading as pyoderma gangrenosum","volume":"30","author":"Oh","year":"2005","journal-title":"Clin Exp Dermatol"},{"issue":"5","key":"10.1016\/j.det.2010.03.008_bib127","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.jaad.2006.01.039","article-title":"Topical tacrolimus neither prevents nor abolishes ultraviolet-induced erythema","volume":"55","author":"Gambichler","year":"2006","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.det.2010.03.008_bib128","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1365-2230.2007.02367.x","article-title":"Lack of response of alopecia areata to pimecrolimus cream","volume":"32","author":"Rigopoulos","year":"2007","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"10.1016\/j.det.2010.03.008_bib129","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.jaad.2004.08.012","article-title":"Randomized controlled trial of pimecrolimus 1% cream for treatment of facial acne vulgaris","volume":"52","author":"Tan","year":"2005","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.det.2010.03.008_bib130","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jaad.2009.03.046","article-title":"A prospective randomized trial of topical pimecrolimus for cetuximab-associated acnelike eruption","volume":"61","author":"Scope","year":"2009","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"10.1016\/j.det.2010.03.008_bib131","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1001\/archderm.144.9.1236","article-title":"Pimecrolimus: a novel treatment for cetuximab-induced papulopustular eruption","volume":"144","author":"Eiling","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2010.03.008_bib132","series-title":"Comprehensive dermatologic drug therapy","first-page":"671","article-title":"Topical calcineurin inhibitors","author":"Lin","year":"2007"},{"issue":"3","key":"10.1016\/j.det.2010.03.008_bib133","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1440-0960.2009.00543.x","article-title":"Granuloma faciale successfully treated with topical tacrolimus","volume":"50","author":"Patterson","year":"2009","journal-title":"Australas J Dermatol"},{"issue":"4","key":"10.1016\/j.det.2010.03.008_bib134","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/j.1365-2133.2008.08988.x","article-title":"Efficacy and safety of tacrolimus ointment 0.1% vs. betamethasone 17-valerate 0.1% in the treatment of chronic paronychia: an unblinded randomized study","volume":"160","author":"Rigopoulos","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2010.03.008_bib135","article-title":"Clinicopathological characteristics of lichen planus pigmentosus and\u00a0its response to tacrolimus ointment: an open label, non-randomized, prospective study","author":"Al-Mutairi","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.det.2010.03.008_bib136","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1365-2133.2006.07181.x","article-title":"Tacrolimus ointment 0.1% in pityriasis alba: an open-label, randomized, placebo-controlled study","volume":"155","author":"Rigopoulos","year":"2006","journal-title":"Br J\u00a0Dermatol"},{"issue":"8","key":"10.1016\/j.det.2010.03.008_bib137","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1610-0387.2008.06575.x","article-title":"Annular lichenoid dermatitis of youth\u2013a further case in a 12-year-old girl","volume":"6","author":"Kleikamp","year":"2008","journal-title":"J Dtsch Dermatol Ges"},{"issue":"2","key":"10.1016\/j.det.2010.03.008_bib138","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2340\/00015555-0410","article-title":"Successful treatment of genital pruritus using topical immunomodulators as a single therapy in multi-morbid patients","volume":"88","author":"Weisshaar","year":"2008","journal-title":"Acta Derm Venereol"},{"issue":"6","key":"10.1016\/j.det.2010.03.008_bib139","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1097\/MLG.0b013e31804b1aad","article-title":"Tacrolimus: a new option in therapy-resistant chronic external otitis","volume":"117","author":"Caffier","year":"2007","journal-title":"Laryngoscope"},{"issue":"10","key":"10.1016\/j.det.2010.03.008_bib140","first-page":"944","article-title":"Incontinentia pigmenti: treatment of IP with topical tacrolimus","volume":"8","author":"Jessup","year":"2009","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.det.2010.03.008_bib141","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/09546630903200620","article-title":"Plasma cell cheilitis, successfully treated with topical 0.03% tacrolimus ointment","author":"Jin","year":"2009","journal-title":"J Dermatolog Treat"},{"issue":"3","key":"10.1016\/j.det.2010.03.008_bib142","doi-asserted-by":"crossref","first-page":"10","DOI":"10.5070\/D398D1X0M2","article-title":"Granulomatous cheilitis","volume":"10","author":"Kovich","year":"2004","journal-title":"Dermatol Online J"},{"issue":"1","key":"10.1016\/j.det.2010.03.008_bib143","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/7140.2006.00004","article-title":"Successful treatment of inflammatory linear verrucous epidermal nevus with tacrolimus and fluocinonide","volume":"10","author":"Mutasim","year":"2006","journal-title":"J Cutan Med Surg"},{"issue":"1","key":"10.1016\/j.det.2010.03.008_bib144","first-page":"106","article-title":"Tacrolimus ointment for 'jogger's nipples'","volume":"32","author":"Tomi","year":"2007","journal-title":"Clin Exp Dermatol"},{"issue":"3","key":"10.1016\/j.det.2010.03.008_bib145","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1365-2230.2006.02121.x","article-title":"Juvenile plantar dermatosis responding to topical tacrolimus ointment","volume":"31","author":"Shipley","year":"2006","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"10.1016\/j.det.2010.03.008_bib146","first-page":"36","article-title":"The effect of tacrolimus on lower extremity ulcers: a case study and review of the literature","volume":"54","author":"Miller","year":"2008","journal-title":"Ostomy Wound Manage"},{"issue":"3","key":"10.1016\/j.det.2010.03.008_bib147","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.jaad.2006.10.021","article-title":"Treatment of localized lichen myxedematosus of discrete type with tacrolimus ointment","volume":"58","author":"Rongioletti","year":"2008","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.det.2010.03.008_bib148","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/09546630601156330","article-title":"Topical tacrolimus for the treatment of lichen simplex chronicus","volume":"18","author":"Aschoff","year":"2007","journal-title":"J Dermatolog Treat"},{"issue":"2","key":"10.1016\/j.det.2010.03.008_bib149","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1365-2230.2005.02012.x","article-title":"Lichenoid tattoo reaction responding to topical tacrolimus ointment","volume":"31","author":"Campbell","year":"2006","journal-title":"Clin Exp Dermatol"},{"issue":"3","key":"10.1016\/j.det.2010.03.008_bib150","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1468-3083.2007.02315.x","article-title":"Tacrolimus ointment, an interesting adjunctive therapy for childhood linear IgA bullous dermatosis","volume":"22","author":"Dauendorffer","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"9","key":"10.1016\/j.det.2010.03.008_bib151","first-page":"906","article-title":"Successful treatment of patch type mycosis fungoides with tacrolimus ointment 0.1%","volume":"5","author":"Rallis","year":"2006","journal-title":"J Drugs Dermatol"},{"issue":"10","key":"10.1016\/j.det.2010.03.008_bib152","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/j.1365-4632.2008.03710.x","article-title":"Necrolytic acral erythema: successful treatment with topical tacrolimus ointment","volume":"47","author":"Manzur","year":"2008","journal-title":"Int J Dermatol"},{"issue":"3","key":"10.1016\/j.det.2010.03.008_bib153","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1159\/000112935","article-title":"Tacrolimus 0.1% ointment: is it really effective in plasma cell vulvitis? Report of four cases","volume":"216","author":"Virgili","year":"2008","journal-title":"Dermatology"},{"issue":"4","key":"10.1016\/j.det.2010.03.008_bib154","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1024\/0301-1526.33.4.260","article-title":"Successful treatment of stasis dermatitis with topical tacrolimus","volume":"33","author":"Dissemond","year":"2004","journal-title":"Vasa"},{"issue":"7","key":"10.1016\/j.det.2010.03.008_bib155","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/j.1468-3083.2007.02071.x","article-title":"A case of cheilitis glandularis superimposed on oral lichen planus: successful palliative treatment with topical tacrolimus and pimecrolimus","volume":"21","author":"Erkek","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.det.2010.03.008_bib156","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2310\/7750.2008.07026","article-title":"Use of pimecrolimus cream in disorders other than atopic dermatitis","volume":"12","author":"Day","year":"2008","journal-title":"J Cutan Med Surg"},{"issue":"5","key":"10.1016\/j.det.2010.03.008_bib157","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1080\/09546630801955341","article-title":"Pimecrolimus 1% cream for pruritus in postmenopausal diabetic women with vulvar lichen simplex chronicus: a prospective non-controlled case series","volume":"19","author":"Kelekci","year":"2008","journal-title":"J Dermatolog Treat"},{"issue":"5","key":"10.1016\/j.det.2010.03.008_bib158","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/j.1468-3083.2008.02963.x","article-title":"Frontal fibrosing alopecia: treatment with oral dutasteride and topical pimecrolimus","volume":"23","author":"Katoulis","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.det.2010.03.008_bib159","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000096923","article-title":"Long-term efficacy of occlusive therapy with topical pimecrolimus in severe dyshidrosiform hand and foot eczema","volume":"214","author":"Schurmeyer-Horst","year":"2007","journal-title":"Dermatology"},{"issue":"2","key":"10.1016\/j.det.2010.03.008_bib160","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000182267","article-title":"A case of recurrent eruptive pseudo-angiomatosis that responded well to pimecrolimus 1% cream","volume":"218","author":"Tan","year":"2009","journal-title":"Dermatology"},{"issue":"1","key":"10.1016\/j.det.2010.03.008_bib161","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1365-2230.2008.02753.x","article-title":"A case of follicular mucinosis treated successfully with pimecrolimus","volume":"34","author":"Gorpelioglu","year":"2009","journal-title":"Clin Exp Dermatol"},{"issue":"3","key":"10.1016\/j.det.2010.03.008_bib162","first-page":"340","article-title":"Treatment of pityriasis rubra pilaris with pimecrolimus cream 1%","volume":"6","author":"Gregoriou","year":"2007","journal-title":"J Drugs Dermatol"},{"issue":"1","key":"10.1016\/j.det.2010.03.008_bib163","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1468-3083.2007.02280.x","article-title":"Successful treatment of severe pyoderma gangrenosum with pimecrolimus cream 1%","volume":"22","author":"Bellini","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.det.2010.03.008_bib164","doi-asserted-by":"crossref","first-page":"22","DOI":"10.5070\/D307H281VQ","article-title":"Pimecrolimus 1 percent cream and pulsed dye laser in treatment of a patient with reticular erythematous mucinosis syndrome","volume":"13","author":"Mansouri","year":"2007","journal-title":"Dermatol Online J"},{"issue":"2","key":"10.1016\/j.det.2010.03.008_bib165","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1365-4632.2008.03392.x","article-title":"Two cases of Zoon's balanitis treated with pimecrolimus 1% cream","volume":"47","author":"Bardazzi","year":"2008","journal-title":"Int J Dermatol"},{"issue":"7","key":"10.1016\/j.det.2010.03.008_bib166","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/j.1365-4632.2007.03145.x","article-title":"An exploratory study to evaluate the efficacy of pimecrolimus cream 1% for the treatment of pityriasis alba","volume":"46","author":"Fujita","year":"2007","journal-title":"Int J Dermatol"}],"container-title":["Dermatologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863510000495?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863510000495?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T08:55:06Z","timestamp":1740128106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733863510000495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":166,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S0733863510000495"],"URL":"https:\/\/doi.org\/10.1016\/j.det.2010.03.008","relation":{},"ISSN":["0733-8635"],"issn-type":[{"value":"0733-8635","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}